STAT

JUNE 26, 2024

Three months since an outbreak of avian influenza in U.S. dairy cattle was declared, the country is failing to take the necessary steps to get in front of the virus and possibly contain its spread among cows, according to interviews with more than a dozen experts and current and former government officials. The country still does not have a sufficient testing infrastructure in place, nor a full understanding of how the virus is moving within herds and to new herds, experts say.

362

362

PharmaVoice

JUNE 25, 2024

A COVID and flu duo could ease manufacturing and administration, potentially driving higher vaccination rates, said Moderna’s VP of North American medical affairs.

Vaccines 276

Vaccines 276

ALiEM - Pharm Pearls

JUNE 25, 2024

Dr. Sara Krzyzaniak (podcast host and Stanford University PD) and Dr. Michelle Lin (ALiEM Founder/UCSF) are joined by Dr. Jessica Bod (Yale University Clerkship Director and 2024 CDEM Clerkship Director of the Year award winner) in this episode to discuss how one might approach their emergency medicine sub-internship. Dr. Bod shares her her wealth of experience and wisdom to provide not only general advice but also answers more detailed questions like: What are some things NOT to do on a rotatio

243

243

BioPharma Dive

JUNE 27, 2024

A growing cohort of biotechs, from Biohaven to Neurocrine to Jazz, hope research on ion channels will bring them new drugs and big business — much like it has done for Vertex.

136

136

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JUNE 25, 2024

Firearm violence is officially a public health crisis in the U.S. — Surgeon General Vivek Murthy says so. In a new advisory published on Tuesday, Murthy calls attention to the health toll of gun violence, describing the size of the crisis while laying out a roadmap of research and policy interventions to curb its effects. “My hope is that framing just the profound impact and pervasive impact of gun violence in our country … can firmly take it out of the realm of politics and

362

362

PharmaVoice

JUNE 27, 2024

Neuroscience pipelines are reawakening as biotechs prove to the pharma giants that the field is still worth the investment.

307

307

Express Pharma

JUNE 26, 2024

Dr. Reddy’s Laboratories announced that its subsidiary Dr. Reddy’s Laboratories SA has signed a definitive agreement with Haleon, a consumer healthcare company, for the purchase of shares of Northstar Switzerland SARL, a Haleon group company, to acquire Haleon’s global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy (“NRT”) category outside of the United States.

118

118

STAT

JUNE 27, 2024

In the pit of the pandemic, with no one to see and nowhere to go, and horrors unfolding daily outside the front door, there was for many a reliable bright spot: the 5 p.m. drink that would mark the end of the workday. Drinking, which was already on the rise before 2020, became a coping mechanism for overburdened parents, burnt-out workers, the traumatized, and the bored.

348

348

PharmaVoice

JUNE 24, 2024

With a career focused on striking deals, Kaan Cartel is hoping to lead the Flagship-backed biotech with an mRNA platform into its next phase of growth.

267

267

Pharmafile

JUNE 25, 2024

AstraZeneca has announced that Tagrisso (osimertinib) in combination with pemetrexed and platinum-based chemotherapy has been approved in Japan for the first line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) whose tumours have exon 19 deletions or exon 21 mutations.

Chemotherapy 119

Chemotherapy 119

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

JUNE 24, 2024

Explore how digital twins are transforming healthcare and drug discovery, with success stories showcasing their impact in the biopharma industry. Learn about their journey from concept to real-world applications.

117

117

STAT

JUNE 24, 2024

Since Texas’ ban on abortion went into effect, infant deaths in the state increased by nearly 13%, according to a new analysis published on Monday in JAMA Pediatrics. In the rest of the country, infant mortality increased less than 2% over the same period. “We had read the literature that was showing an association [of infant death increases] with prior abortion restrictions or states that are hostile to abortion,” said lead author Alison Gemmill, a demographer and perinatal

363

363

PharmaVoice

JUNE 26, 2024

The decades-long story of how a first-in-class blood cancer treatment went from bench to bedside.

254

254

The Pharmacist

JUNE 26, 2024

EXCLUSIVE Pharmacy closures in deprived areas are not only impacting physical access to a local pharmacy. They may also be exacerbating health inequalities for those who are less likely to access online services. The Pharmacist’s exclusive mapping of pharmacy closures suggested that the most deprived areas in England have lost nearly five times as many […] The post Analysis: Pharmacy closures risk exacerbating digital divides appeared first on The Pharmacist.

Online Pharmacies 114

Online Pharmacies 114

pharmaphorum

JUNE 26, 2024

Fresh from reporting encouraging results with its obesity drug candidate petrelintide, Zealand Pharma has raised an impressive $1 billion from a new share offering.The Danish biotech started the fundraising process earlier this week with an expectation of raising $900 million but easily overshot that target, evidence once again of huge investor interest in companies developing a new generation of obesity drugs.

113

113

STAT

JUNE 25, 2024

Michigan has led the nation in making inroads with its farmers as it has worked to contain spread of H5N1 bird flu infections in dairy cows. Now the state’s health authorities are trying to do the same in looking for undetected infections among farmworkers. The Michigan Department of Health and Human Services is working with an undisclosed number of farms to try to assess the risk to workers of becoming infected with the virus, which has spread to at least 25 farms in the state in the pas

357

357

Express Pharma

JUNE 28, 2024

Indian Pharmaceutical Alliance (IPA) concluded the 9th edition of the Global Pharmaceutical Quality Summit 2024. The theme for the summit was, ‘Advances in Manufacturing and Quality – Patient Centricity’. The two-day summit brought together industry leaders, global regulators, quality experts, and stakeholders to foster knowledge exchange and deliberate on areas of importance in shaping the pharmaceutical landscape in India.

Biosimilars 108

Biosimilars Documentation 108

Outsourcing Pharma

JUNE 27, 2024

The pharmaceutical industry is making significant strides toward sustainability, with companies across the sector implementing various Environmental, Social, and Governance (ESG) initiatives.

110

110

Welltopia Pharmacy

JUNE 26, 2024

Zenith supplement is a new and effective weight loss solution for people suffering from overweight problems. Weight loss is a significant health challenge that affects millions of people worldwide. The prevalence of obesity and overweight conditions has surged, leading to various health complications such as diabetes, cardiovascular diseases, and joint problems.

Diabetes 111

Diabetes 111

STAT

JUNE 27, 2024

The U.S. Supreme Court rejected a controversial bankruptcy deal in which the owners of Purdue Pharma sought to contribute up to $6 billion in exchange for immunity from further lawsuits. The ruling means the company and its creditors — numerous states, cities and counties, as well as Native American governments — will have to negotiate a new settlement.

Immunity 346

Immunity Immunization 346

The Pharmacist

JUNE 27, 2024

The president of the Primary Care Pharmacy Association (PCPA) has said he 'would not wish' Additional Roles Reimbursement Scheme (ARRS) or Pharmacy First funding 'to be subsumed' into core general practice funding, as called for recently by the Doctors' Association UK (DAUK). In a 10-point manifesto presented to prospective MPs last week, the DAUK’s GP […] The post PCPA president defends multidisciplinary team as doctors ask for ARRS funding appeared first on The Pharmacist.

110

110

BioPharma Dive

JUNE 26, 2024

Obesity drugs like Wegovy are proving useful in many other diseases. Polycystic ovary syndrome, a chronic condition that can cause infertility, may be one.

120

120

pharmaphorum

JUNE 27, 2024

Explore a methodological approach for discovering the emotional patient journey through patient insights. Understand the importance of emotional connections in healthcare.

110

110

STAT

JUNE 27, 2024

WASHINGTON — A House committee overwhelmingly passed four bills on Thursday that would expand Medicare coverage of obesity drugs and cancer screening blood tests and place guardrails around Medicare’s discretion in covering drugs and devices approved by the Food and Drug Administration. The House Ways & Means Committee passed obesity drug coverage legislation that would offer a limited pathway for adults 65 and older to get their weight loss drugs paid for by Medicare.

339

339

Express Pharma

JUNE 28, 2024

The 10th edition of PharmaLytica, organised by Informa Markets in India concluded at HITEX, Hyderabad. With a focus on redefining the pharmaceutical industry in the post-COVID era, PharmaLytica 2024 offered a platform for stakeholders to engage in discussions covering the full spectrum of pharma machinery and packaging, lab analytical and cleanroom solutions, and pharmaceutical ingredients.

Packaging 105

Packaging Biosimilars Labelling Vaccines 105

BioPharma Dive

JUNE 26, 2024

The findings provide early proof that multiple doses of a gene editing medicine can be safely administered with additive effects, overcoming a key constraint of the complex therapies.

109

109

pharmaphorum

JUNE 27, 2024

Unleash the power of generative AI (GenAI) in the pharmaceutical industry to achieve excellence in product launch strategies. Learn how this cutting-edge technology can drive your business forward.

108

108

STAT

JUNE 25, 2024

A bipartisan group of lawmakers is urging the Biden administration to prohibit Medicare Advantage insurers from using artificial intelligence tools to deny care until it completes a systematic review of their accuracy and effects on patients. In a letter sent Tuesday, the lawmakers cited a STAT investigation in calling on the Centers for Medicare and Medicaid Services to beef up oversight of AI and algorithmic tools that discriminate against old and sick patients.

344

344

Express Pharma

JUNE 28, 2024

The osteoporosis market, the prevailing metabolic bone disorder globally, which is characterised by reduced bone mineral density and increased fracture risk, is set to experience a compound annual growth rate (CAGR) of 5.4 per cent across the seven major markets (7MM*) from $10.5 billion in 2023 to $17.9 billion in 2033, forecasts GlobalData. GlobalData’s latest report, “Seven-Market Drug Forecast and Market Analysis”, reveals the rising popularity of expensive anabolic therapies and increasing

Biosimilars 105

Biosimilars Compounding Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

JUNE 26, 2024

AstraZeneca has received Japanese approval for Tagrisso plus chemotherapy as first-line treatment for non-small cell lung cancer (NSCLC).

Chemotherapy 125

Chemotherapy 125

vizient

JUNE 25, 2024

The planned acquisition brings together two of the industry’s most trusted advisors to help healthcare organizations deliver high-quality patient care to their communities.

111

111

STAT

JUNE 24, 2024

Suicide rates in the United States increased approximately 36% between 2000 and 2022, according to updated data from the National Center for Health Statistics. Suicide was responsible for just under 50,000 deaths in 2022 (the last year with complete statistics) — an all-time high. As this appalling trend continues, offering mental health assessments and care in primary care settings could help save lives.

347

347

Express Pharma

JUNE 23, 2024

The X20 system has been an essential component of countless industrial applications for the last 20 years, providing dependable performance and pushing productivity to unprecedented levels. The X20 has transformed industrial automation with its small size and potent features, enabling machines all around the world to function accurately and effectively.

111

111

Drug Patent Watch

JUNE 27, 2024

Introduction Patent portfolios are critical assets for pharmaceutical companies, providing market exclusivity and protecting revenue streams for drug products. Effective management of drug patent portfolios requires strategic planning, ongoing evaluation, and adaptation to the evolving pharmaceutical landscape. This article explores key best practices for optimizing drug patent portfolios to maximize value and maintain competitive advantage.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

JUNE 25, 2024

The European Commission has approved the first twice-yearly injection for relapsing and primary progressive multiple sclerosis (RMS and PPMS). Roche highlighted that as a 10-minute injection, OCREVUS ® (ocrelizumab) subcutaneous has the same twice-yearly schedule as the intravenous (IV) infusion, which was the first therapeutic to be approved for both RMS and PPMS.

Immunity 109

Immunity Immunization 109